Less Ads, More Data, More Tools Register for FREE

Pin to quick picksPTY.L Regulatory News (PTY)

  • There is currently no data for PTY

Trading Statement

5 Feb 2019 09:30

RNS Number : 1076P
Parity Group PLC
05 February 2019
 

Parity Group PLC

5 February 2019

Parity Group plc ("Parity" or the "Group")

Board Changes and Trading Update

 

Parity (AIM:PTY), the technology focussed consultancy and staffing business, today announces changes to the Board and provides a post-close update on trading in respect of the year ended 31 December 2018.

 

Board changes

 

The Board is pleased to announce the appointment of Matthew Bayfield as Chief Executive Officer. This appointment will ensure Parity has the breadth of management to drive progress with our strategic focus on the growth opportunities we see in data consultancy services. Alan Rommel, currently Chief Executive Officer, will move into the role of Chief Operating Officer, a Board position.

 

Matthew Bayfield joined Parity's senior management team in May 2018 to drive the development and growth of the data proposition within the Parity Consultancy Services business. His experience is closely aligned to the new strategic focus of the Group as an acknowledged expert in the data market, having operated on the Group Board for Ogilvy & Mather as their Head of Data for EMEA, as well as founding and leading a number of data strategy, research and insight businesses, taking three to successful commercial exit.

 

Alan Rommel, having returned the business to profitable growth, restructured it to focus on its strong core capabilities, and significantly reduced its debt, will now focus on digitising aspects of the core business and ensuring the operational structure effectively supports the strategy to create sustainable growth of the Group.

 

 

Trading update

 

Having been greatly encouraged by the opportunities won and identified in higher-margin data consultancy services, the Board has restructured the Parity Consultancy Services division ("PCS") to focus on this market. We see strong synergies with our Parity Professionals division ("PP") which, whilst continuing to grow its own revenues, is able to introduce PCS services to a broader client base and offer a flexible portfolio of services, whether clients want us to consult and deliver a solution, or want us to provide the talent to support their programmes.

 

The Group expects to deliver growth in revenues and to meet the recently revised market expectations for adjusted profit before tax(1) in the financial year ended 31 December 2018. Net debt is expected to be lower than the balance at 31 December 2017 of £1.6m.

 

 

 

Given the scale of the opportunity we see in data consultancy, we believe the time is right to accelerate our programme of investment in management, marketing and brand development. The Board expects to remain profitable during this period of increased investment, though adjusted profit before tax(1) is now expected to be lower in 2019 than expected for 2018. However, the subsequent improved alignment of our operational structure with the market opportunity, enhanced relationship management, and greater market outreach with a refined proposition will provide a sound basis for sustained profitable growth in future years.

 

Matthew Bayfield commented: "Parity has a strong reputation for providing trusted advice having built and nurtured relationships with both clients and contractors in the IT space for over 45 years. Building on our strengths, we can provide advice and resources that reflect our heritage of IT and data experience. Data is now of greater importance than ever and Parity can empower and enable clients to take advantage of this. Now is the time to invest in building the capability and capacity we need to take full advantage of this opportunity."

 

John Conoley, Non-Executive Chairman of Parity Group, commented:

"We are confident that the Group's focus and investment in data consultancy services will provide a strong foundation for sustained profitable growth in future years. We are delighted to appoint Matthew to the position of CEO. Alan Rommel, supported by our CFO Roger Antony, has worked tirelessly to drive Parity's turnaround and Matthew is ideally placed to accelerate this strategy. 2019 looks like it will be an exciting year and I wish Matthew luck in leading us onward."

 

Notes

(1) Adjusted profit before tax represents Profit before tax from Continuing Operations prior to non-recurring items

 

 

The following details in relation to the appointment of Mr Matthew Bayfield, aged 44, are disclosed in accordance with Schedule 2(g) of the AIM Rules:

 

Current directorships

Past directorships held within the last five years

Field London Limited

nhouse Commercial Limited

nhouse Developments Limited

Turn SQ Limited

 

Mr Bayfield holds 500,000 share options in the Company which are exerciseable from 3 May 2021 subject to performance conditions, at a price of 13.25 pence per share.

 

There are no other disclosures required in accordance with Schedule 2(g) of the AIM Rules.

 

Certain information contained in this announcement would have constituted inside information (as defined by Article 7 of Regulation (EU) No 596/2014) ("MAR") prior to its release as part of this announcement and is disclosed in accordance with the Company's obligations under Article 17 of MAR.

 

 

Contacts:

Parity Group PLC www.parity.net

John Conoley (Chairman) 0208 543 5353

Matthew Bayfield (CEO)

 

WH Ireland Limited www.whirelandcb.com

Mike Coe / Chris Savidge +44 (0) 117 945 3470

 

MHP Communications Parity@mhpc.com

Katie Hunt / Kelsey Traynor +44 (0)203 128 8100

 

 

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
 
END
 
 
TSTSSUSUIFUSESE
Date   Source Headline
1st Feb 20217:00 amRNSContract win
28th Jan 20217:00 amRNSTrading Statement
25th Nov 20207:00 amRNSDirector/PDMR Shareholding - Options Grant
22nd Sep 20207:00 amRNSInterim results
3rd Sep 20207:00 amRNSFramework Agreement and Notice of Interim Results
27th Aug 202011:41 amRNSHolding(s) in Company
11th Aug 20207:00 amRNSPartnership with CyberGym
20th Jul 20207:00 amRNSTrading Update
17th Jun 20207:00 amRNSDirector/PDMR Shareholding
11th Jun 202010:54 amRNSResult of AGM
10th Jun 20208:54 amRNSDirector/PDMR Shareholding
8th Jun 20207:00 amRNSDirectorate Change
27th May 202011:33 amRNSHolding(s) in Company
19th May 202010:59 amRNSNotice of AGM and Posting of Accounts
11th May 202011:07 amRNSHolding(s) in Company
29th Apr 20209:27 amRNSDirectorate Change
24th Apr 20207:00 amRNSGrant of Options
16th Apr 20207:00 amRNSFinal Results
14th Apr 202010:12 amRNSNotice of Results
31st Mar 20207:00 amRNSTrading Statement
21st Jan 20207:00 amRNSHolding(s) in Company
14th Jan 20207:00 amRNSTrading Update
19th Dec 20199:50 amRNSFramework Agreement
19th Nov 20197:00 amRNSDirector/PDMR Shareholding
13th Nov 20197:00 amRNSHoT regarding revenue share on AI data platform
26th Sep 20194:52 pmRNSGrant of Options
20th Sep 20197:00 amRNSHalf-year Report
22nd Aug 20197:00 amRNSHolding(s) in Company
19th Aug 20194:38 pmRNSHolding(s) in Company
30th Jul 20197:00 amRNSNotice of Interim Results
11th Jul 20199:56 amRNSHolding(s) in Company
13th Jun 20195:53 pmRNSDirector Disclosures
30th May 201911:59 amRNSResult of AGM
20th May 20193:32 pmRNSHolding(s) in Company
8th May 20197:00 amRNSPosting of Accounts
18th Apr 201911:37 amRNSDirector/PDMR Shareholding
17th Apr 201910:36 amRNSDirector/PDMR Shareholding
16th Apr 20197:00 amRNSSenior Management Appointment
16th Apr 20197:00 amRNSFinal Results
8th Apr 20197:00 amRNSDirectorate Change
29th Mar 20197:00 amRNSTrading Update
1st Mar 201911:50 amRNSHolding(s) in Company
26th Feb 20197:00 amRNSContract
25th Feb 20198:11 amRNSBlock listing Interim Review
20th Feb 20191:38 pmRNSHolding(s) in Company
8th Feb 201910:32 amRNSHolding(s) in Company
5th Feb 20199:30 amRNSTrading Statement
8th Nov 20187:00 amRNSDirector/PDMR Shareholding
7th Nov 20187:00 amRNSDirector/PDMR Shareholding
2nd Nov 20184:02 pmRNSHolding(s) in Company

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.